- Page 1 and 2: Rashtrasant Tukadoji Maharaj Nagpur
- Page 3 and 4: have been allocated for seminar. Ma
- Page 5: The marks will be given in all exam
- Page 9 and 10: Pharmacology APPENDIX-C Semester Pa
- Page 11 and 12: Biotechnology APPENDIX-E Semester P
- Page 13 and 14: Industrial Pharmacy APPENDIX-G Seme
- Page 15 and 16: Clinical Pharmacy APPENDIX-I Semest
- Page 17 and 18: Pharmaceutical Management APPENDIX-
- Page 19 and 20: RECOMMENDED BOOKS: 1. Skoog, DA, Ho
- Page 21 and 22: 6. C.R. Kothari, 2004. “Research
- Page 23 and 24: Study of newer excipients like cycl
- Page 25 and 26: Semester-II Subject code: MC-S7 Sub
- Page 27 and 28: 6. S. K. Gupta, Drug screening meth
- Page 29 and 30: 8. Protein & peptide drug delivery
- Page 31 and 32: Semester-III Subject code: MPH-S13
- Page 33 and 34: Syllabus Prescribed for Degree of M
- Page 35 and 36: Semester-II Validation & CGMP (MC-S
- Page 37 and 38: 4. RECENT ADVANCES IN FOLLOWING CAT
- Page 39 and 40: Semester-III Subject code: MPC-S13
- Page 41 and 42: Syllabus prescribed for Degree of M
- Page 43 and 44: Subject code: MPL-P4 Subject: ADVAN
- Page 45 and 46: RECOMMENDED BOOKS: 1. Goodman and G
- Page 47 and 48: 5. Koda and Kimble, Hand book of Ap
- Page 49 and 50: 2. To measure blood pressure using
- Page 51 and 52: 4. Craig, C.R. and Stitzel, B.E.; M
- Page 53 and 54: 6. Chaudhari R.D., Herbal Drug Indu
- Page 55 and 56: Subject code: MPG-S10 Subject: HERB
- Page 57 and 58:
Semester-III Subject code: MPG-S13
- Page 59 and 60:
5. Joe Sambrooke, 2001. Molecular c
- Page 61 and 62:
Subject code: MBT-S10 Subject: FERM
- Page 63 and 64:
Semester-III Subject code: MBT-S13
- Page 65 and 66:
4. Current Good Manufacturing Pract
- Page 67 and 68:
7. P. P. Sharma. Cosmetics- Formula
- Page 69 and 70:
Semester-III Subject code: MQA-S13
- Page 71 and 72:
6. King and Turco, Sterile Dosage F
- Page 73 and 74:
3. Leon Lachmann. Pharmaceutical Do
- Page 75 and 76:
Subject code: MIP-P9 Subject: ADVAN
- Page 77 and 78:
Semester-I Syllabus Prescribed for
- Page 79 and 80:
Subject code: MPI-P4 Subject: INFOR
- Page 81 and 82:
concept of homology modeling potent
- Page 83 and 84:
4. Alberts, B., Bray ,D., Lewis J.,
- Page 85 and 86:
targets (from bioinformatics method
- Page 87 and 88:
7. Avery‟s Drug Treatment, 4 th E
- Page 89 and 90:
RECOMMENDED BOOKS : 1. Roger and Wa
- Page 91 and 92:
Subject code: MCP-P10 Subject: CLIN
- Page 93 and 94:
5. Practice Standards & Definitions
- Page 95 and 96:
5. G.E. Trease and W.C. Evans., Pha
- Page 97 and 98:
14. Toms, G., Marine Pharmacognosy
- Page 99 and 100:
Subject code: MNP-P10 Subject: STAN
- Page 101 and 102:
Syllabus prescribed for Degree of M
- Page 103 and 104:
Semester-II Validation & CGMP (MC-S
- Page 105 and 106:
Subject code: MPM-P9 Subject: PHARM
- Page 107 and 108:
Elective Subjects: Group A: Pharmac
- Page 109 and 110:
Subject code: MPHE2 Subject: FERMEN
- Page 111 and 112:
7. Hospital drug policy Pharmacy an
- Page 113 and 114:
Validation, Computer System Validat
- Page 115 and 116:
GROUP B: PHARMACEUTICAL CHEMISTRY S
- Page 117 and 118:
Subject code: MPCE3 Subject: COMBIN
- Page 119 and 120:
Subject code: MPCE5 Subject: ORGANI
- Page 121 and 122:
GROUP C: PHARMACOLOGY, CLINICAL PHA
- Page 123 and 124:
Subject code: MPLE3 Subject: IMMUNO
- Page 125 and 126:
10. Neurological disorders. 11. Tec
- Page 127 and 128:
GROUP D: PHARMACOGNOSY, NATURAL PRO
- Page 129 and 130:
3. Profiles for commercial cultivat
- Page 131 and 132:
RECOMMENDED BOOKS: 1. Textbook of I
- Page 133 and 134:
Subject code: MQAE2 Subject: HUMAN
- Page 135 and 136:
4. Specifications and quality: mate
- Page 137 and 138:
Setting a goal for the control subj
- Page 139:
138